1. [Less ventilator-associated pneumonia after oral decontamination with chlorhexidine; a randomised trial].
- Author
-
Koeman M, van der Ven AJ, Hak E, Joore JC, Kaasjager HA, de Smet AM, Ramsay G, Dormans TP, Aarts LP, de Bel EE, Hustinx WN, van der Tweel I, Hoepelman IM, and Bonten MJ
- Subjects
- Administration, Topical, Adult, Anti-Bacterial Agents administration & dosage, Anti-Bacterial Agents therapeutic use, Anti-Infective Agents, Local administration & dosage, Chlorhexidine administration & dosage, Colistin administration & dosage, Colistin therapeutic use, Critical Care, Double-Blind Method, Drug Combinations, Female, Gram-Negative Bacteria drug effects, Gram-Negative Bacteria isolation & purification, Gram-Positive Bacteria drug effects, Gram-Positive Bacteria isolation & purification, Humans, Length of Stay, Male, Middle Aged, Mouth microbiology, Oropharynx microbiology, Placebos, Time Factors, Trachea microbiology, Anti-Infective Agents, Local therapeutic use, Chlorhexidine therapeutic use, Mouth drug effects, Pneumonia, Bacterial prevention & control, Ventilators, Mechanical adverse effects
- Abstract
Objective: To determine the effect of oral decontamination with either chlorhexidine (CHX, 2%) or the combination chlorhexidine-colistin (CHX-COL, 2%-2%) on the frequency and the time to onset of ventilator-associated pneumonia in Intensive Care patients., Design: Double blind, placebo-controlled, multicentre, randomised trial., Methods: Consecutive ICU patients needing at least 48 h of mechanical ventilation were enrolled in a randomized trial with 3 arms: CHX, CHX-COL, and placebo (PLAC). The trial medication was administered in the oral cavity every 6 h. Oropharyngeal swabs were obtained daily and analysed quantitatively for Gram-positive and Gram-negative microorganisms. Endotracheal colonisation was monitored twice weekly. Ventilator-associated pneumonia was diagnosed on the basis of a combination of clinical, radiological and microbiological criteria., Results: Of 385 patients included, 130 received PLAC, 127 CHX and 128 CHX-COL. Baseline characteristics in the three groups were comparable. The daily risk of ventilator-associated pneumonia was reduced in both treatment groups compared to PLAC: 65% (HR= 0.352; 95% CI: 0.160-0.791; p = 0.012) for CHX and 55% (HR= 0.454; 95%/ CI: 0.224-0.925; p = 0.030) for CHX-COL. CHX-COL provided a significant reduction in oropharyngeal colonisation with both Gram-negative and Gram-positive microorganisms, whereas CHX significantly affected only colonisation with Gram-positive microorganisms. There were no differences in the duration of mechanical ventilation, ICU-stay or ICU-survival., Conclusion: Oral decontamination of the oropharyngeal cavity with chlorhexidine or the combination chlorhexidine-colistin reduced the incidence and the time to onset ofventilator-associated pneumonia.
- Published
- 2008